Altimmune Inc (ALT)
8.405
+0.36
(+4.41%)
USD |
NASDAQ |
Nov 21, 16:00
8.49
+0.08
(+1.01%)
Pre-Market: 08:47
Altimmune Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 81.02% |
| Viking Therapeutics Inc | -- |
| Amgen Inc | 61.07% |
| Avid Bioservices Inc | 14.22% |
| NovaBay Pharmaceuticals Inc | 65.26% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -64.43% |
| Return on Assets | -58.37% |
| Return on Invested Capital | -64.43% |
| Profit Margin (Quarterly) | -456.9K% |
| Operating Margin (Quarterly) | -495.3K% |
| Return on Net Operating Assets | -1.54K% |